Sonika Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Sonika Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2011-05-13 New Delhi, Delhi Active Unlisted Active Compliant
Share
View plans Plan
SL Sonika Life Sciences Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sonika Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
68/100
Trust Score
Moderate

Sonika Life Sciences Private Limited is assessed as Moderate with a Trust Score of 68/100. Sonika Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 09 Jul 2026 from the latest processed filings. Sonika Life Sciences Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
70/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 1 satisfied (10.35 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Icici Bank1 48.0 cr
Compliance Score: 70/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: NSDL.
  • 2 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SONIKA JASUJA 01234567 Director 01/04/2018 6 yrs Approved
VISHAL JASUJA 01234567 Director 01/04/2018 6 yrs Approved
NEELAM SETH 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
24 allotment(s) · 0 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Group entityRelationship% held
Wells Biosciences Private Limited Associate Company 74.00%

Key managerial personnel: SONIKA JASUJA (Whole-time director) · VISHAL JASUJA (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 60
Growth signals & trust indicators
Operating for 15+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence66/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment52/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view47/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
03 Dec 2018
Charge satisfied
Icici Bank
04 Dec 2017
Director ceased
ANKIT SETH
30 Sep 2017
Director appointed
NEELAM SETH (Director)
06 Jan 2014
Charge created
Icici Bank - 10.35 Lakh
05 Aug 2013
Securities allotted
20000 Equity Shares Without Differential Rights - 2.00 Lakh raised
30 Jul 2013
Securities allotted
20000 Equity Shares Without Differential Rights - 2.00 Lakh raised
28 Jun 2013
Securities allotted
30000 Equity Shares Without Differential Rights - 3.00 Lakh raised
27 Jun 2013
Securities allotted
30000 Equity Shares Without Differential Rights - 3.00 Lakh raised
22 Mar 2013
Securities allotted
40000 Equity Shares Without Differential Rights - 4.00 Lakh raised
21 Mar 2013
Director ceased
NEELAM SETH
11 Mar 2013
Director ceased
SONIKA JASUJA
07 Mar 2013
Securities allotted
40000 Equity Shares Without Differential Rights - 4.00 Lakh raised
16 Feb 2013
Securities allotted
69000 Equity Shares Without Differential Rights - 6.90 Lakh raised
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a minority stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 24 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Aeran Metalics Pvt Ltd U27203WB1995PTC075951 Howrah, West Bengal, India
Viotol Remedies Private Limited U74999RJ2018PTC062930 Kalwad, Rajasthan, India
Amritsagar Formulation Private Limited U24117UP2019PTC112735 Hapur, Uttar Pradesh, India
Shrivallabh Pittie Ventures Limited U64200MH2002PLC136641 Mumbai, Maharashtra, India
Edria Services Private Limited U74999WB2017PTC223723 Kolkata, West Bengal, India
Eutheon Life Sciences Private Limited U74999DL2017PTC314434 New Delhi, Delhi, India
Shivansh Metalloys Private Limited U74999HR2021PTC096117 Thanesar, Haryana, India
Intercontinental Business Matrix Private Limited U51900GJ2019PTC107916 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sonika Life Sciences Private Limited before audits and certifications: compliance score 70/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sonika Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Sonika Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Sonika Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sonika Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sonika Life Sciences Private Limited an active company?

Sonika Life Sciences Private Limited has MCA status “Active” with a compliance score of 70/100 (Moderate).

Is Sonika Life Sciences Private Limited financially healthy?

Sonika Life Sciences Private Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Sonika Life Sciences Private Limited?

Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sonika Life Sciences Private Limited?

Promoters hold a minority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Sonika Life Sciences Private Limited have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Sonika Life Sciences Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 70/100 (Moderate).

Is it risky to lend to Sonika Life Sciences Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.